Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Labeling: Label Mixup: HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg may have potentially been mislabeled as one of the following drugs: hydrALAZINE HCl, Tablet, 100 mg, NDC 23155000401, Pedigree: AD73652_4, EXP: 5/29/2014; CLINDAMYCIN HCL, Capsule, 300 mg, NDC 00591312001, Pedigree: AD67989_1, EXP: 5/28/2014.
HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228282011.
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Reason Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
Reason Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets…
Reason Presence of foreign substance: plastic-like substance.
Reason Failed Impurities/Degradation Specifications
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.